Literature DB >> 18639520

IFN-gamma acts as anti-angiogenic cytokine in the human cornea by regulating the expression of VEGF-A and sVEGF-R1.

Vijay K Kommineni1, Chandrasekharam N Nagineni, Abitha William, Barbara Detrick, John J Hooks.   

Abstract

Inflammatory processes within the cornea are known to be associated with corneal neovascularization (CN). We examined the effects of inflammatory mediators on the expression of angiogenic factors by corneal cells. TNF-alpha and IL-1 induced VEGF-A secretion by corneal fibroblasts (HCRF) and this was inhibited significantly by IFN-gamma. Constitutively secreted VEGF-A by corneal epithelial cells (HCE) was not affected by these cytokines. Moreover, sVEGF-R1(sFlt-1) secretion by HCRF was stimulated significantly by IFN-gamma. JAK-STAT pathway inhibitor reversed the effects of IFN-gamma on VEGF-A and sFlt-1 secretion by HCRF. RT-PCR analysis showed that IFN-gamma influences the expression of VEGF-A and sFlt-1 by affecting their mRNA level. IFN-gamma inhibited TGF-beta induced VEGF-A secretion but not sVEGF-R1 secretion. This is the first report demonstrating the inhibitory and stimulatory effects of IFN-gamma on VEGF-A and sFlt-1 secretion, respectively. Our results suggest that IFN-gamma acts as an anti-angiogenic cytokine in the human cornea.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18639520      PMCID: PMC2997485          DOI: 10.1016/j.bbrc.2008.07.042

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  24 in total

1.  Blockade of TGF-beta by in vivo gene transfer of a soluble TGF-beta type II receptor in the muscle inhibits corneal opacification, edema and angiogenesis.

Authors:  T Sakamoto; H Ueno; K Sonoda; T Hisatomi; K Shimizu; H Ohashi; H Inomata
Journal:  Gene Ther       Date:  2000-11       Impact factor: 5.250

2.  Photochemical preparation of a pyridone containing tetracycle: a Jak protein kinase inhibitor.

Authors:  James E Thompson; Rose M Cubbon; Richard T Cummings; Linda S Wicker; Robert Frankshun; Barry R Cunningham; Patricia M Cameron; Peter T Meinke; Nigel Liverton; Youmin Weng; Julie A DeMartino
Journal:  Bioorg Med Chem Lett       Date:  2002-04-22       Impact factor: 2.823

3.  Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas.

Authors:  W Philipp; L Speicher; C Humpel
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-08       Impact factor: 4.799

4.  Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization.

Authors:  C M Lai; M Brankov; T Zaknich; Y K Lai; W Y Shen; I J Constable; I Kovesdi; P E Rakoczy
Journal:  Hum Gene Ther       Date:  2001-07-01       Impact factor: 5.695

5.  Immunohistochemical localization of vascular endothelial growth factor, transforming growth factor alpha, and transforming growth factor beta1 in human corneas with neovascularization.

Authors:  C Cursiefen; C Rummelt; M Küchle
Journal:  Cornea       Date:  2000-07       Impact factor: 2.651

6.  Transforming growth factor-beta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: involvement of mitogen-activated protein kinases.

Authors:  Chandrasekharam N Nagineni; William Samuel; Sahrudaya Nagineni; Komanduri Pardhasaradhi; Barbara Wiggert; Barbara Detrick; John J Hooks
Journal:  J Cell Physiol       Date:  2003-12       Impact factor: 6.384

Review 7.  The biology of VEGF and its receptors.

Authors:  Napoleone Ferrara; Hans-Peter Gerber; Jennifer LeCouter
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

8.  Dexamethasone inhibits interleukin-1beta-induced corneal neovascularization: role of nuclear factor-kappaB-activated stromal cells in inflammatory angiogenesis.

Authors:  Shintaro Nakao; Yasuaki Hata; Muneki Miura; Kousuke Noda; Yusuke N Kimura; Shuhei Kawahara; Takeshi Kita; Toshio Hisatomi; Toru Nakazawa; Yiping Jin; M Reza Dana; Michihiko Kuwano; Mayumi Ono; Tatsuro Ishibashi; Ali Hafezi-Moghadam
Journal:  Am J Pathol       Date:  2007-08-09       Impact factor: 4.307

9.  Inhibition of corneal neovascularization by recombinant adenovirus-mediated sFlk-1 expression.

Authors:  Hui Yu; Jihong Wu; Huiming Li; Zhanli Wang; Xiafang Chen; Yuhua Tian; Miaoying Yi; Xunda Ji; Jialie Ma; Qian Huang
Journal:  Biochem Biophys Res Commun       Date:  2007-08-01       Impact factor: 3.575

10.  Synthesis and activity of new aryl- and heteroaryl-substituted pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain.

Authors:  J Scott Sawyer; Bryan D Anderson; Douglas W Beight; Robert M Campbell; Michael L Jones; David K Herron; John W Lampe; Jefferson R McCowan; William T McMillen; Nicholas Mort; Stephen Parsons; Edward C R Smith; Michal Vieth; Leonard C Weir; Lei Yan; Faming Zhang; Jonathan M Yingling
Journal:  J Med Chem       Date:  2003-09-11       Impact factor: 7.446

View more
  20 in total

1.  TGF-β1 signaling and Krüppel-like factor 10 regulate bone marrow-derived proangiogenic cell differentiation, function, and neovascularization.

Authors:  Akm Khyrul Wara; ShiYin Foo; Kevin Croce; Xinghui Sun; Basak Icli; Yevgenia Tesmenitsky; Fehim Esen; Jung-Soo Lee; Malayannan Subramaniam; Thomas C Spelsberg; Eli I Lev; Dorit Leshem-Lev; Reena L Pande; Mark A Creager; Anthony Rosenzweig; Mark W Feinberg
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

2.  Proangiogenic Function of T Cells in Corneal Transplantation.

Authors:  Antonio Di Zazzo; Maryam Tahvildari; Brinda Subbarayal; Jia Yin; Thomas H Dohlman; Takenori Inomata; Alireza Mashaghi; Sunil K Chauhan; Reza Dana
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

3.  Absence of IFN-γ accelerates thrombus resolution through enhanced MMP-9 and VEGF expression in mice.

Authors:  Mizuho Nosaka; Yuko Ishida; Akihiko Kimura; Yumi Kuninaka; Masanori Inui; Naofumi Mukaida; Toshikazu Kondo
Journal:  J Clin Invest       Date:  2011-06-06       Impact factor: 14.808

4.  Differential cytokine responses in human and mouse lymphatic endothelial cells to cytokines in vitro.

Authors:  G V Chaitanya; S E Franks; W Cromer; S R Wells; M Bienkowska; M H Jennings; A Ruddell; T Ando; Y Wang; Y Gu; M Sapp; J M Mathis; P A Jordan; A Minagar; J S Alexander
Journal:  Lymphat Res Biol       Date:  2010-09       Impact factor: 2.589

5.  The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction.

Authors:  Seth G Thacker; Celine C Berthier; Deborah Mattinzoli; Maria Pia Rastaldi; Matthias Kretzler; Mariana J Kaplan
Journal:  J Immunol       Date:  2010-08-30       Impact factor: 5.422

6.  Pro-angiogenic effect of IFNgamma is dependent on the PI3K/mTOR/translational pathway in human retinal pigmented epithelial cells.

Authors:  Baoying Liu; Lisa Faia; Mengjun Hu; Robert B Nussenblatt
Journal:  Mol Vis       Date:  2010-02-10       Impact factor: 2.367

7.  Transforming growth factor-β regulates the expression of anosmin (KAL-1) in human retinal pigment epithelial cells.

Authors:  Raghavan Raju; Bixi Jian; John J Hooks; Chandrasekharam N Nagineni
Journal:  Cytokine       Date:  2013-01-26       Impact factor: 3.861

Review 8.  Corneal transparency: genesis, maintenance and dysfunction.

Authors:  Yureeda Qazi; Gilbert Wong; Bryan Monson; Jack Stringham; Balamurali K Ambati
Journal:  Brain Res Bull       Date:  2009-05-27       Impact factor: 4.077

9.  IL-11 expression in retinal and corneal cells is regulated by interferon-gamma.

Authors:  Chandrasekharam N Nagineni; Vijay K Kommineni; Abitha William; John J Hooks; Barbara Detrick
Journal:  Biochem Biophys Res Commun       Date:  2009-11-12       Impact factor: 3.575

10.  Vascular endothelial growth factor receptor-1 (VEGFR-1) expression in human corneal fibroblast decreased with age.

Authors:  Alexandre Berthaut; Pezhman Mirshahi; Nadia Benabbou; Dalel Azzazene; Camille Bordu; Amu Therwath; Jean-marc Legeais; Massoud Mirshahi
Journal:  Mol Vis       Date:  2009-09-29       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.